Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1‐ or IDH2‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study

American Journal of Hematology(2024)10.1002/ajh.27366Source: DataRank Database

Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1‐ or IDH2‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study is a research paper published in American Journal of Hematology (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.73)OA: bronzeTopics (46)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Shai Shimony ORCID,Rory M. Shallis ORCID,Yiwen Liu ORCID,Guillaume Berton ORCID,Eva J. Schaefer

Live enrichment

PubMed:38751104 OpenAlex:https://openalex.org/W4396972100

National Institutes of Health/National Cancer Institute

Grant: #1P50CA254838-01

National Institute of Health

Grant: 5K12CA001727-27

National Institutes of Health/National Cancer Institute

Grant: #P30 CA008748

FWCI

2.73

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.27366

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.27366

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27366

journalhttps://doi.org/10.1002/ajh.27366

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38751104

Fields of Study

Acute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentAcute Lymphoblastic Leukemia researchAdultAgedFemaleHumansMaleMiddle AgedAntineoplastic Combined Chemotherapy ProtocolsBridged Bicyclo Compounds, HeterocyclicCohort StudiesInduction ChemotherapyIsocitrate DehydrogenaseLeukemia, Myeloid, AcuteMutationSulfonamides

MeSH Terms

AdultAgedAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansIsocitrate DehydrogenaseMaleMiddle AgedMutationSulfonamidesCohort StudiesLeukemia, Myeloid, AcuteBridged Bicyclo Compounds, HeterocyclicInduction Chemotherapy

Keywords

VenetoclaxIDH1MedicineIDH2Myeloid leukemiaHypomethylating agentOncologyInternal medicineChemotherapyMutantLeukemiaBiologyGeneGeneticsDNA methylation